Abstract
In the classic studies of Straub (1910), as well as Clark (1937), one finds the first attempts to show a relationship between the localization of cardiac glycosides by cardiac cells and their effect on the heart. Thus, Straub’s early experiments showed that excised frog heart contained certain receptive sites which bound a fatal concentration of digitalis from the perfusate. Furthermore, it was observed that the receptive capacity of heart muscle became saturated after one passage of digitalis through it, provided the perfusate concentration of this drug was sufficiently high. On the other hand, by meticulous calculations, Clark showed that since it took 2 μg of ouabain to arrest a frog ventricle weighing 1 g and containing 3 × 108 cells, the lethal effect was due to the fixation of 107 ouabain molecules per cardiac cell. He also pointed out that the fixed ouabain molecules could not cover more than 3% of the surface of the cardiac cell.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akera, T., Baskin, S.I., Tobin, T., Brody, T.M.: Ouabain: Temporal relationship between the inotropic effect and in vitro binding to and dissociation from (Na+K)-activated ATPase. Naunyn-Schmiedebergs Arch. Pharmakol. 277, 151–162 (1973)
Akera, T.: Membrane adenosine triphosphatase: A digitalis receptor? Science 198, 569–574 (1977)
Akera, T., Temma, K., Weist, S.A., Brody, T.M.: Reduction of equilibrium binding of cardiac glycosides and related compounds to Na + K ATPase as a possible mechanism for potassium-induced reversal of their toxicity. Naunyn-Schmiedebergs Arch. Pharmakol. 304,157–165 (1978)
Alexander, W.R., Williams, L.T., Lefkowitz, R.J.: Identification of cardiac ß-adrenergic receptors by 3H alprenolol binding. Proc. Natl. Acad. Sci. U.S.A. 72,1564–1568 (1975)
Allen, J.C., Entman, M.L., Schwartz, A.: The nature of the transport adenosine triphosphatase-digitalis complex. VIII. The relationship between in vivo-formed (3H-ouabainNa +, K -adenosine triphosphatase) complex and ouabain-induced positive inotropism. J. Pharmakol. Exp. Ther. 192,105–112 (1975)
Baker, P.F., Willis, J.S.: Binding of the cardiac glycoside ouabain to intact cells. J. Physiol. (Lond.) 224,441–462 (1972)
Baskin, S.I., Dutta, S., Marks, B.H.: The effects of diphenylhydantion and potassium on the biological activity of ouabain in the guinea-pig heart. Br. J. Pharmacol. 47, 85–96 (1973)
Bentfeld, M., Lüllmann, H., Peters, T., Proppe, D.: Interdependence of ion transport and the action of ouabain in heart muscle. Br. J. Pharmacol. 61,19–27 (1977)
Binnion, P.F., Das Gupta, R.: Tritiated digoxin metabolism after prior treatment with pro- pranolol or diphenyhydantion sodium. Int. J. Clin. Pharmacol. 12, 96–101 (1975)
Boardman, L.J., Lamb, J.F., McCall, D.: Uptake of 3H-ouabain and Na pump rates in cells cultured in ouabain. J. Physiol. (Lond.) 225,619–635 (1972)
Bossaller, C., Schmoldt, A.: Dehydro-digitoxosides of digitoxigenin and digoxigenin: Binding to beef heart (Nat +K+)-ATPase in relation to unchanged digitoxosides. NaunynSchmiedebergs Arch. Pharmakol. 306,11–15 (1979)
Busse, F., Lüllmann, H., Peters, T.: Concentration dependence of the binding of ouabain to isolated guinea pig atria. J. Cardiovasc. Pharm. 1, 687–698 (1979)
Clark, A.J.: Handbuch der experimentellen Pharmakologie. General pharmacol. Berlin: Julius Springer 1937
Deutscher, R.N., Harrison, D.C., Goldman, R.H.: The relation between myocardial 3H-di- goxin concentration and its homodynamic effects. Am. J. Cardiol. 29, 47–55 (1972)
Dutta, S., Marks, B.H., Smith, C.R.: Distribution and excretion of ouabain-H3 and dihy- dro-ouabain-H3 in rats and sheep. J. Pharmakol. Exp. Ther. 142, 223–230 (1963)
Dutta, S., Goswami, S., Lindower, J.O., Marks, B.H.: Subcellular distribution of 3H-digoxin in isolated guinea pig and rat heart. J. Pharmakol. Exp. Ther. 159, 324–334 (1968a)
Dutta, S., Goswami, S., Datta, D.K., Lindower, J.O., Marks, B.H.: The uptake and binding of six radiolabeled cardiac glycosides by guinea-pig hearts and isolated sarcoplasmic reticulum. J. Pharmakol. Exp. Ther. 164,10–21 (1968b)
Dutta, S., Marks, B.H.: Factors that regulate 3H-ouabain accumulation by the isolated guinea pig heart. J. Pharmakol. Exp. Ther. 170, 318–325 (1969)
Dutta, S., Marks, B.H.: Species and ionic influences on the accumulation of digitalis glycosides by isolated perfused hearts. Br. J. Pharmacol. 46,401–408 (1972)
Dutta, S., Rhee, H.M., Marks, B.H.: 3H Ouabain accumulation and Na+-K+-ATPase activity in relation to therapeutic, toxic, and lethal doses of ouabain in dogs. In: Recent advances in studies on cardiac structure and metabolism: Myocardial biology, Vol.4. Dhalla, N.S. (ed.), pp. 119–129. Baltimore: Park Press 1974
Dutta, S., Marks, B.H., Stephen, P.M.: The uptake and subcellular distribution of radiolabelled metabolites of digitoxin in the guinea-pig isolated perfused heart. Br. J. Pharmacol. 56, 437–441 (1976)
Dutta, S., Marks, B.H., Schoener, E.P.: Accumulation of radioactive cardiac glycosides by various brain regions in relation to the dysrhythmogenic effect. Br. J. Pharmacol. 59,101–106 (1977)
Erdmann, E., Schoner, W.: Ouabain receptor interaction in (Na+ + K+)-ATPase preparation from different tissues and species. Determination of kinetic constants and dissociation constants. Biochim. Biophys. Acta 307,386–398 (1973a)
Erdmann, E., Schoner, W.: Ouabain receptor interaction in (Nat + K+)-ATPase preparation. II. Effect of cations and nucleotides on rate constants and dissociation constants. Biochim. Biophys. Acta 330, 302–315 (1973b)
Erdmann, E., Schoner, W.: Properties of the receptor for cardiac glycosides. Klin. Wochenschr. 52, 705–718 (1974)
Erdmann, E.: Cell membrane receptors for cardiac glycosides in the heart. Basic Res. Car-diol. 72,315–325 (1977)
Flasch, H., Heinz, N.: Correlation between inhibition of (Na +, K)-membrane-ATPase and positive inotropic activity of cardenolides in isolated papillary muscles of guinea pig. Naunyn-Schmiedebergs Arch. Pharmacol. 304, 37–44 (1978)
Forester, W., Lewis, R.P., Weissler, A.M., Wilke, T.A.: The onset and magnitude of contractile response to commonly used digitalis glycosides in normal subjects. Circulation 49, 517–521 (1974)
Fricke, U., Gerber, H.-S., Klaus, W., Wollert, U.: Comparison of the subcellular distribution of 3H-strophanthine and 3H-digitoxin in guinea pig hearts. Naunyn-Schmiedebergs Arch. Pharmacol. 263,266–267 (1969)
Fricke, U., Klaus, W.: Dependence of the cardiac uptake of digitalis glycosides on the extracellular calcium concentration in guinea-pig isolated hearts. Eur. J. Pharmacol. 30,182–187 (1975)
Fricke, U., Hollborn, U., Klaus, W.: Inotropic action, myocardial uptake and subcellular distribution of ouabain, digoxin, and digitoxin in isolated rat hearts. Naunyn-Schmiedebergs Arch. Pharmacol. 288, 195–214 (1975)
Fricke, U.: Neuere Erkenntnisse über den Wirkungsmechanismus der Herzglykoside. Fortschr. Med. 94,1839–1845 (1976)
Fricke, U.: Myocardial activity of inhibitors of the Na+-K+-ATPase: Differences in the mode of action and subcellular distribution pattern of N-ethylmaleimide and ouabain. Naunyn-Schmiedebergs Arch. Pharmacol. 303, 197–204 (1978)
Fricke, U., Klaus, W.: Evidence for two different Na+ dependent [3H]-ouabain binding sites of a Na+ -Kt -ATPase of guinea pig hearts. Br. J. Pharmacol. 61, 423–428 (1977)
Fricke, U., Klaus, W.: Sodium-dependent cardiac glycoside binding: Experimental evidence and hypothesis. Br. J. Pharmacol. 62, 255–257 (1978)
Fujino, S., Kawagishi, S., Eguchi, N., Tanaka, M.: Binding site of ouabain in cardiac muscle cell and its positive inotropic effect in cat. Jpn. J. Pharmacol. 21, 423–424 (1971)
Gerber, H.G., Fricke, U., Klaus, W., Wollert, U.: Über die intracelluläre Verteilung von 3H-Digitoxin im Meerschweinchenherzen. Naunyn-Schmiedebergs Arch. Pharmacol. 260,119–120 (1968)
Godfraind, T., Lesne, M.: Estimation of digitoxin uptake by isolated cardiac and smooth muscle preparations. Arch. Int. Pharmacodyn. Ther. 166, 195–199 (1967)
Godfraind, T., Lesne, M.: Uptake of cardiac glycosides in relation to their actions in isolated cardiac muscle. Br. J. Pharmacol. 46, 488–497 (1972)
Godfraind, T., Lesne, M., Pousti, A.: The action of diphenylhydantoin upon drug binding, ionic effects and inotropic effects of ouabain. Arch. Int. Pharmacodyn. 191,66–73 (1971)
Godfraind, T.: Cardiac glycoside receptors in the heart. Biochem. Pharmacol. 24, 823–827 (1975)
Godfraind, T., Ghysel-Burton, J.: Binding sites related to ouabain-induced stimulation or inhibition of sodium pump. Nature 265, 165–166 (1977)
Goldman, R.H., Coltant, J.D., Friedman, J.P., Nola, G.T., Berke, D.K., Schweizer, E., Harrison, D.C.: The inotropic effects of digoxin in hyperkalemia. Relation to Na-K ATPase inhibition in the intact animal circulation. 48, 830–838 (1973)
Goldstein, A.: The interactions of drugs and plasma proteins. Pharmacol. Rev. 1,102–165 (1949)
Greenberger, N.J., MacDermott, R.P., Martin, J.F., Dutta, S.: Intestinal absorption of six tritium-labelled digitalis glycosides in rats and guinea pigs. J. Pharmakol. Exp. Ther. 167,265–273 (1969)
Hall, R.J., Gelbart, A., Silverman, M., Goldman, R.H.: Studies on digitalis-induced arrhythmias in glucose — and insulin-induced hypokalemia. J. Pharmacol. Exp. Ther. 201,711–722 (1977)
Harvey, S.C., Pieper, G.R.: Intracellular distribution of digitoxin-C14 in the heart. J. Pharm. Exp. Ther. 116, 14–27 (1955)
Hopkins, B.E., Lloyd, B.L., Taylor, R.F.: Myocardial digoxin uptake in pressure overload right hypertrophy. Cardiovasc. Res. 8, 701–706 (1974)
Hougen, T.J., Smith, T.W.: Inhibition of myocardial monovalent cation active transport by subtoxic doses of ouabain in the dog. Circ. Res. 42, 856–863 (1978)
Hougen, T.J., Brian, L.L., Smith, T.W.: Effects of inotropic and arrhythmogenic digoxin doses and of digoxin-specific antibody on myocardial monovalent cation transport in the dog. Circ. Res. 44, 23–31 (1979)
Kawagishi, S.: Subcellular distribution of tritium labelled cardiac glycosides in isolated cat and guinea pig hearts. Folia Pharmacol. Jpn. 67, 243–251 (1971)
Kim, N.D., Bailey, L.E., Dresel, P.E.: Correlation of the subcellular distribution of digoxin with the positive inotropic effect. J. Pharmacol. Exp. Ther. 181(2), 377–385 (1972)
Ku, D.D., Akera, T., Tobin, T., Brody, T.M.: Comparative species studies on the effect of monovalent cations and ouabain on cardiac Na+ K+-adenosine triphosphatase and contractile force. J. Pharmacol. Exp. Ther. 197,458–469 (1976)
Kuschinsky, K., Lahrtz, H., Lüllmann, H., Zwieten, P.A., van: Accumulation and release of 3H-digoxin by guinea-pig heart muscle. Br. J. Pharmacol. Chemother. 30,317–328 (1967a)
Kuschinsky, K., Lüllmann, H, Schmitz, G., Zwieten, P.A., van: The binding of 3H-digoxin by heart muscle tissue. Naunyn-Schmiedebergs Arch. Pharmakol. Exp. Path. 258,297–308 (1967b)
Kuschinsky, K., Lüllmann, H., Zwieten, P.A., van: A comparison of the accumulation and release of H3-ouabain and H3-digitoxin by guinea pig heart muscle. Br. J. Pharmacol. Chemother. 32, 598–608 (1968a)
Kuschinsky, K., Lüllmann, H., Zwieten, P.A., van: The binding of 3H-peruvoside by guinea-pig isolated atria. Arzneim. Forsch. 12, 1602–1605 (1968b)
Kuschinsky, K., Lüllmann, H., Zwieten, P.A., van: The binding of 3H-digitoxigenin by guinea atrial tissue. Br. J. Pharmacol. 34,613–622 (1968c)
Kuschinsky, K., Lüllmann, H., Zwieten, P.A., van: The uptake of 3H-ouabain and 3H-digitoxin by guinea pig atria, previously extracted with glycerol. Eur. J. Pharmacol. 4,228–230 (1968d)
Luchi, R.J., Park, C.D., Waldhausen, J.A.: Relationship between myocardial ouabain content and inotropic activity. Am. J. Physiol. 220(4), 906–910 (1971)
Lüllmann, H., Peters, T., Zwieten, P.A., van: The distribution of 3H-labelled cardenolides between isolated guinea-pig atrial tissue and circulating, oxygenated whole blood. Br. J. Pharmacol. 36, 276–285 (1969)
Lüllmann, H., Zwieten, P.A., van: The kinetic behavior of cardiac glycosides in vivo, measured by isotope technique. J. Pharm. Pharmacol. 21, 1–8 (1969)
Lüllmann, H., Ravens, U.: The time courses of the changes in contractile force and in trans-membrane potentials induced by cardiac glycosides in guinea-pig papillary muscle. Br. J. Pharmacol. 49, 377–390 (1973)
Lüllmann, H., Peters, T., Ravens, U.: Studies on the kinetics of [3H]-ouabain uptake and exchange in the isolated papillary muscle of the guinea pig. Br. J. Pharmacol. 53, 99–107 (1975)
Marks, B.H., Dutta, S., Gauthier, J., Elliott, D.: Distribution in plasma uptake by the heart and excretion of ouabain-H3 in human subjects. J. Pharm. Exp. Ther. 145, 351–356 (1964)
Marzo, A., Ghirardi, P.: Subcellular distribution of K-strophanthoside (3H) in isolated guinea-pig hearts. Biochem. Pharmacol. 23, 2817–2824 (1974)
Marzo, A., Ghirardi, P., Preti, A., Lombardo, A.: Subcellular distribution of deslantoside-C 3H in isolated guinea-pig hearts. Interaction of other drugs. Biochem. Pharmacol. 25, 371–376 (1976)
Matsui, H., Schwartz, A.: Mechanism of cardiac glycoside inhibition of the (Na+-K+)-de-pendent ATPase from cardiac tissue. Biochim. Biophys. Acta 151, 655–663 (1968)
Moran, N.C.: Contraction dependency of the positive inotropic action of cardiac glycosides. Circ. Res. 21, 727–740 (1967)
Peters, T., Raben, R.H., Wassermann, O.: Evidence for a dissociation between positive inotropic effect and inhibition of the Na -K -ATPase by ouabain, cassaine, and their alkylating derivatives. Eur. J. Pharmacol. 26 166–174 (1974)
Reiter, M.: Die Wertbestimmung inotrop wirkender Arzneimittel am isolierten Papillarmuskel. Arzneim. Forsch. (Drug Res.) 17, 1249–1253 (1967)
Repke, K.R.H., Portius, H.J.: Über die Identität der lonenpumpen ATPase in der Zellmembrane des Herzmuskels mit einem Digitalis-Rezeptorenenzym. Experientia 19, 452–458 (1963)
Repke, K.R.H., Dittrich, F., Berlin, P., Portius, H.J.: On physical forces governing cardiac glycosides activity. Ann. N.Y. Acad. Sci. 242, 737–739 (1974)
Rhee, H.M.: Subcellular distribution of ouabain and changes in Na K ATPase activity in relation to the pharmacological effects of ouabain in dog: Effects of DPH and KC1 infusion. Ph.D. Dissertation, The Ohio State University, pp. 38–64 (1973)
Rhee, H.M., Dutta, S., Marks, B.H.: Cardial Na K ATPase activity during positive inotropic and toxic actions of ouabain. Eur. J. Pharmacol. 37, 141–153 (1976)
Roth-Schechter, B.F., Okita, G.T., Anderson, D., Richardson, F.F.: Relationship among contraction drug bindingand positive inotropic action of digoxin. J. Pharm. Exp. Ther. 171, 249–255 (1970)
Schwartz, A., Allen, J.C., Winkle, W.B., van, Munson, R.: Further studies on the correlation between the inotropic action of ouabain and its interaction with the Na +, K+-adenosine triphosphatase: Isolated perfused rabbit and cat hearts. J. Pharm. Exp. Ther. 191, 119–127 (1974)
Schwartz, A., Lindenmeyer, G.E., Allen, J.C.: The sodium-potassium adenosine triphosphatase: Pharmacological, physiological, and biochemical aspects. Pharmacol. Rev. 27, 3–134 (1975)
Selden, R., Neill, W.A.: Myocardial uptake of ouabain in intact dog and man. J. Pharmacol. Exp. Ther. 198, 951–962 (1975)
Sharma, V.K., Banerjee, S.P.: The effect of 6-hydroxydopamine on specific [3]ouabain binding to some sympathetically innervated organs of the cat. Molec. Pharmacol. 13, 796–804 (1977)
Sharma, V.K., Banerjee, S.P.: Specific [3H]ouabain binding to rat heart and skeletal muscle: Effects of thyroidectomy. Molec. Pharmacol. 14, 122–129 (1978)
Sjoerdsma, A., Fischer, M.D.: The fixation of radioactive digitoxin by isolated hearts. Circulation 4, 100–104 (1951)
Steiness, E., Valentin, N.: Myocardial uptake of digoxin in chronically digitalized dogs. Br. J. Pharmacol. 58, 553–559 (1976)
Stephen, P.M., Dutta, S., Marks, B.H.: The uptake and subcellular distribution of radio-labeled metabolites of digoxin in the isolated perfused guinea-pig heart. NaunynSchmiedebergs Arch. Pharmacol. 292, 251–254 (1976)
Straub, W.: Quantitative Untersuchungen über den Chemismus der Strophanthinwirkung. Biochem. Z. 28, 392–407 (1910)
Taubert, K., Shapiro, W.: Altered uptake after a toxic dose. In: Recent advances in studies on cardiac structure and metabolism. Basic functions of cations in myocardial activity, Vol. 5. Fleckenstein, A., Dhalla, N.S. (eds.), pp. 388–393. Baltimore: University Park Press 1975
Thomas, R., Allen, J., Pitts, B.J.R., Schwartz, A.: Cardenotide analogs: An explanation for the unusual properties of AY22241. Eur. J. Pharmacol. 53, 227–237 (1979)
Wellsmith, N.V., Alstyne, V.E., Bartschat, D.K., Poe, S.L., Lindenmayer, G.E.: Two receptor forms for ouabain in cardiac sarcolemma. Fed. Prod. 38, 371 (1979)
Wilson, W.E., Sivitz, W.I., Hanna, L.T.: Inhibition of calf brain membrane sodium-and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model. Molec. Pharmacol. 6, 449–459 (1970)
Zavecz, J.H.: Personal Communication, 1974
Editor information
Editors and Affiliations
Additional information
Dedicated to Professor Bernard H. Marks, on the occasion of his 60th birthday
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dutta, S. (1981). Cardiac Uptake and Binding of Cardiac Glycosides. In: Greeff, K. (eds) Cardiac Glycosides. Handbook of Experimental Pharmacology, vol 56 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68166-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-68166-0_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68168-4
Online ISBN: 978-3-642-68166-0
eBook Packages: Springer Book Archive